Clinical Trials Browser

Phase 1/2 × Advanced Haematological Malignancies × acalabrutinib × Clear all

NCT04630756 2025-04-09

AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Blood Cancer

Phase 1/2 Completed

40 enrolled 31 charts

Advanced Haematological Malignancies